Winterville, NC, United States of America

Jeffrey Ahlers

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jeffrey Ahlers

Introduction

Jeffrey Ahlers is an accomplished inventor based in Winterville, NC (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of beta-hemoglobinopathies. With a total of two patents to his name, Ahlers is recognized for his innovative approaches to addressing genetic disorders.

Latest Patents

Ahlers' latest patents focus on compositions and methods for treating beta-hemoglobinopathies. The disclosures provide expression vectors that comprise at least two nucleic acid sequences. These include a nucleic acid sequence encoding an anti-HPRT RNAi and a nucleic acid sequence encoding a gamma globin gene. In some embodiments, the viral vector is a self-inactivating lentiviral vector. The gamma-globin gene is utilized to genetically correct sickle cell disease or β-thalassemia, or to reduce symptoms associated with these conditions.

Career Highlights

Throughout his career, Ahlers has worked with notable companies in the field of gene therapy, including CSL Behring Gene Therapy, Inc. and CSL Gene Therapy Pty Ltd. His work has contributed to advancements in therapeutic strategies for genetic diseases.

Collaborations

Ahlers has collaborated with esteemed colleagues such as Jeffrey S. Bartlett and Chi-Lin Lee. These partnerships have fostered innovation and progress in the research and development of gene therapies.

Conclusion

Jeffrey Ahlers is a prominent inventor whose work in gene therapy has the potential to transform the treatment of beta-hemoglobinopathies. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…